Spots Global Cancer Trial Database for lung neoplasms
Every month we try and update this database with for lung neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE) | NCT03099031 | Venous Thromboe... | Tinzaparin | 18 Years - | LEO Pharma | |
| Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer | NCT00001499 | Carcinoma, Non-... Lung Neoplasms | paclitaxel cisplatin chest radiother... | - | National Institutes of Health Clinical Center (CC) | |
| Icotinib for Completed Resected IB NSCLC With EGFR Mutation | NCT02264210 | Lung Neoplasms Squamous Cell L... Adenocarcinoma ... Adenosquamous C... Large Cell Lung... Bronchial Neopl... Stage IB Non-sm... | Icotinib | 18 Years - 75 Years | Sun Yat-sen University | |
| Extensive Staging in Lung Cancer | NCT02030444 | Lung Neoplasms | PET-MRI and EBU... | - | St. Olavs Hospital | |
| Mapping Sound Propagation Through the Human Lung for Better Diagnosis | NCT03043898 | Bronchomalacia Asthma Lung Neoplasms Lung Diseases, ... Pulmonary Disea... | Lung sound tran... Lung sound reco... | 18 Years - | University of Cambridge | |
| Differentiation of Malig. & Ben. Solitary Pulm. Nodules & Prediction of Clin. Outcome Using Perfus. Analysis of DCEMRI | NCT00172575 | Lung Neoplasms | 20 Years - | National Taiwan University Hospital | ||
| Real World Registry for Use of the Ion Endoluminal System | NCT06004440 | Lung Cancer Multiple Pulmon... Lung Neoplasms Respiratory Tra... Thoracic Neopla... Neoplasms by Si... Neoplasms Lung Diseases Respiratory Tra... | Ion Endoluminal... | 18 Years - | Intuitive Surgical | |
| Extensive Staging in Lung Cancer | NCT02030444 | Lung Neoplasms | PET-MRI and EBU... | - | St. Olavs Hospital | |
| Construction and Effect Evaluation of the Low Load Blood Flow Restriction Training Program for Lung Cancer Patients Complicated With Sarcopenia During Chemotherapy | NCT06347965 | Sarcopenia Lung Neoplasms | Low load blood ... Progressive res... | 18 Years - | Zhejiang University | |
| Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy | NCT02984761 | Lung Neoplasm | Stereotactic Ra... Anatomic Pulmon... | 18 Years - | VA Office of Research and Development | |
| Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer | NCT01580982 | Lung Neoplasms | 18 Years - 85 Years | University of Colorado, Denver | ||
| Thoracic OncoGeriatric Assessment (TOGA) Trials | NCT00591981 | Thoracic Neopla... Lung Neoplasms Esophagus Neopl... Pleural Neoplas... Thymus Neoplasm... | TOGA Tools | 70 Years - | University of Wisconsin, Madison | |
| Evaluation of a Scalable Decision Support and Shared Decision Making Tool for Lung Cancer Screening | NCT04498052 | Early Detection... Lung Neoplasms | EHR-integrated ... | 55 Years - 80 Years | University of Utah | |
| Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | NCT00071136 | Lung Neoplasms | pemetrexed gemcitabine | 18 Years - | Eli Lilly and Company | |
| Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer | NCT02117440 | Lung Neoplasms | 18 Years - | Indiana University | ||
| A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC | NCT03134872 | Lung Neoplasms Carcinoma, Non-... Respiratory Tra... Thoracic Neopla... Lung Diseases Respiratory Tra... Neoplasms by Si... Neoplasm, Bronc... Carcinoma, Bron... | SHR-1210 Carboplatin Pemetrexed | 18 Years - 70 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| Impact on Quality of Life and Health of the CONTINUUM+ CONNECT Remote Monitoring Solution | NCT06379880 | Prostatic Neopl... Lung Neoplasms Breast Neoplasm... Colorectal Neop... | CONTINUUM+ CONN... | 18 Years - | Institut de cancérologie Strasbourg Europe | |
| Real World Registry for Use of the Ion Endoluminal System | NCT06004440 | Lung Cancer Multiple Pulmon... Lung Neoplasms Respiratory Tra... Thoracic Neopla... Neoplasms by Si... Neoplasms Lung Diseases Respiratory Tra... | Ion Endoluminal... | 18 Years - | Intuitive Surgical | |
| A Study to Test Lung Function After Radiation Therapy | NCT01039649 | Lung Neoplasms Neoplasm Metast... | 18 Years - | University of Iowa | ||
| A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements | NCT03093116 | Locally Advance... Metastatic Soli... | Oral repotrecti... | 12 Years - | Turning Point Therapeutics, Inc. | |
| POWER Study (Prospective Transbronchial Microwave + Robotic-Assisted Bronchoscopy) | NCT05299606 | Lung Neoplasms | Transbronchial ... | 22 Years - | Ethicon, Inc. | |
| Lazertinib in Patients With NSCLC With Asymptomatic or Mild Symptomatic Brain Metastases After Failure of EGFR TKI. | NCT05326425 | Lung Neoplasms | lazertinib(YH25... | 20 Years - | Seoul St. Mary's Hospital | |
| A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC | NCT03085069 | Lung Neoplasms Carcinoma, Non-... Respiratory Tra... Lung Disease Respiratory Tra... Neoplasm, Bronc... Carcinoma, Bron... | SHR-1210 | 18 Years - 80 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early Stage Lung Cancer | NCT02933294 | Lung Neoplasms | Triportal pulmo... Uniportal pulmo... | 18 Years - | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| An Observational Study of the Ethnic Impact of Patients Undergoing Second (2nd) Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed | NCT00497770 | Lung Neoplasms | Pemetrexed | 18 Years - | Eli Lilly and Company | |
| Erector Spinae Plane Block Versus Paravertebral Block During Non-intubated Thoracoscopic Lung Resections. | NCT03137576 | Lung Neoplasms | Paravertebral B... Erector Spinae ... | 18 Years - | IRCCS Sacro Cuore Don Calabria di Negrar | |
| Efficacy of EGFR TKIs in Patients With Rare EGFR-mutated NSCLC | NCT01775943 | Lung Neoplasms | - | Ulsan University Hospital | ||
| Efficacy and Safety Evaluation of Sintilimab in Patients With Advanced or Metastatic Non-squamous NSCLC | NCT03607539 | Lung Neoplasms | Sintilimab Pemetrexed Platinum Placebos | 18 Years - 75 Years | Innovent Biologics (Suzhou) Co. Ltd. | |
| Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder | NCT05512377 | Pancreatic Neop... Solid Tumors Biliary Tract C... Lung Neoplasms Bladder Cancer | brigimadlin | 18 Years - | Boehringer Ingelheim | |
| Rehabilitation for Thoracoscopic Lobectomy | NCT04502654 | Lung Neoplasms Rehabilitation Exercise Pain, Postopera... Post Discharge | Actiwatch 2 (Ph... | 18 Years - | Rigshospitalet, Denmark | |
| Neoadjuvant Aliya™ PEF Soft Tissue Ablation With Systemic Therapy in Early-Stage Resectable NSCLC | NCT05583188 | NSCLC | Aliya Pulsed El... Nivolumab plus ... Standard of car... Surgical Resect... | 18 Years - | Galvanize Therapeutics, Inc. | |
| Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma | NCT02549638 | Carcinoma, Squa... Carcinoma, Squa... Squamous Cell C... Lung Neoplasms Cancer of Lung Cancer of the L... Lung Cancer Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... | DNA Extraction | 18 Years - | Mayo Clinic | |
| A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer | NCT02259582 | Nonsquamous Non... | Pemetrexed Carboplatin demcizumab | 21 Years - | Mereo BioPharma | |
| A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC | NCT03134872 | Lung Neoplasms Carcinoma, Non-... Respiratory Tra... Thoracic Neopla... Lung Diseases Respiratory Tra... Neoplasms by Si... Neoplasm, Bronc... Carcinoma, Bron... | SHR-1210 Carboplatin Pemetrexed | 18 Years - 70 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| China Lung Cancer Screening (CLUS) Study Version 2.0 | NCT03975504 | Lung Neoplasms | Low Dose Comput... artificial inte... autofluorescenc... | 45 Years - 75 Years | Shanghai Chest Hospital | |
| Figitumumab Combined With Pegvisomant For Advanced Solid Tumors | NCT00976508 | Colorectal Neop... Lung Neoplasms Breast Neoplasm... Prostatic Neopl... Sarcoma | figitumumab pegvisomant | 10 Years - | Pfizer | |
| Prospective Randomized Trial Comparing the Effectiveness of Continuous Paravertebral Infusion of Local Anesthetics Versus Intravenous Patient-controlled Analgesia on Acute and Chronic Neuropathic Pain After VATS Lobectomy | NCT01703351 | Lung Neoplasms Postoperative P... | 0.5% ropivacain... Fentanyl 500mcg... | 18 Years - 78 Years | Yonsei University | |
| Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib | NCT02759835 | Lung Adenocarci... Lung Neoplasms | osimertinib Local Ablative ... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Association of Psychological Distress in Patients With Lung Cancer | NCT06218901 | Lung Neoplasms Psychological D... Prognosis Facto... Lifestyle, Heal... IMMUNOTHERAPY Targeted Molecu... | immunotherapy Targeted Therap... | 18 Years - | Shanghai Chest Hospital | |
| Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC) | NCT01999985 | Lung Cancer Non-small Cell ... | Dasatinib - 1A Afatinib - 1A Dasatinib - 1B Afatinib - 1B | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Anlotinib Therapy in Patients With Advanced Lung Cancer. | NCT03940404 | Lung Neoplasms | Anlotinib Hydro... | 18 Years - | First People's Hospital of Hangzhou | |
| Association of Psychological Distress in Patients With Lung Cancer | NCT06218901 | Lung Neoplasms Psychological D... Prognosis Facto... Lifestyle, Heal... IMMUNOTHERAPY Targeted Molecu... | immunotherapy Targeted Therap... | 18 Years - | Shanghai Chest Hospital | |
| A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLC | NCT04959981 | Advanced Non-sq... | ERAS-007 ERAS-601 Osimertinib Sotorasib | 18 Years - 99 Years | Erasca, Inc. | |
| Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy | NCT00100256 | Lung Neoplasms Carcinoma, Non-... Carcinoma, Smal... Neoplasm Recurr... | Rhenium (Re 188... | 21 Years - | Andarix Pharmaceuticals | |
| BIO 300 Non-Small Cell Lung Cancer Study | NCT02567799 | Carcinoma, Non-... | BIO 300 Oral Su... Paclitaxel Carboplatin Radiotherapy | 18 Years - | Humanetics Corporation | |
| Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers | NCT03212404 | Lung Neoplasms Carcinoma, Non-... Carcinoma, Smal... Malignant Mesot... Head and Neck C... Melanoma Merkel Cell Car... Renal Cell Carc... Urothelial Carc... Classical Hodgk... Cutaneous Squam... Non Hodgkin Lym... Endometrial Can... | CK-301 (cosibel... | 18 Years - | Checkpoint Therapeutics, Inc. | |
| A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors | NCT06237881 | Advanced Solid ... Melanoma Lung Neoplasms Head and Neck N... | KSQ-001EX Interleukin-2 Cyclophosphamid... Fludarabine | 18 Years - 70 Years | M.D. Anderson Cancer Center | |
| Comparison Between Wedge Resection and Segmentectomy for Ground Glass Opacity- Dominant Stage IA NSCLC | NCT02718365 | Lung Neoplasms Surgery | Wedge resection Segmentectomy | 18 Years - 75 Years | West China Hospital | |
| Circulating Tumor DNA Detection in Surveillance of Surgical Lung Cancer Patients | NCT02696525 | Carcinoma Non-small-cell ... Lung Neoplasms | 18 Years - 80 Years | Peking University People's Hospital | ||
| Audio Technology To Detect Lung Cancer Earlier | NCT03566862 | Lung Neoplasms Cough | Leicester Cough... | 50 Years - | NHS Greater Glasgow and Clyde | |
| Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer | NCT01637376 | Carcinoma, Non-... | Temoporfin | 18 Years - | University of Arkansas | |
| A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome Sequencing | NCT02705404 | Lung Neoplasms Carcinoma Non-s... | Multifocal Tiss... | 18 Years - | Mayo Clinic | |
| A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer | NCT02826161 | Carcinoma, Non-... | Napabucasin Paclitaxel | 18 Years - | Sumitomo Pharma America, Inc. | |
| Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung Tumours | NCT00351962 | Lung Neoplasms Lung Cancer | Fractionated St... | 18 Years - | AHS Cancer Control Alberta | |
| Intensified Chemo-immuno-radiotherapy With Durvalumab for Stage III Non-Small Cell Lung Cancers | NCT04230408 | Lung Neoplasms | Durvalumab | 18 Years - | Latin American Cooperative Oncology Group | |
| Quit Smoking Program for Lung Cancer Patients' Families (The Family Ties Project) | NCT00345891 | Smoking Cessati... | Coping-focused ... | 18 Years - | Duke University | |
| Chest Wall Motion Analysis in Disease | NCT02958683 | Mesothelioma Lung Neoplasms Surgery Cystic Fibrosis Pectus Carinatu... Pectus Excavatu... Empyema, Pleura... Pulmonary Disea... | Chest wall moti... | 16 Years - | Heart of England NHS Trust | |
| Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | NCT00071136 | Lung Neoplasms | pemetrexed gemcitabine | 18 Years - | Eli Lilly and Company | |
| Lung Cancer Rehabilitation After Medical Treatment | NCT04185467 | Lung Neoplasms | Intervention (r... | 18 Years - 75 Years | Nantong University | |
| Smoky Coal Exposure, Genetic Susceptibility, and Lung Cancer in Non-Smoking Women in China | NCT00482118 | Lung Neoplasms | 18 Years - 79 Years | National Institutes of Health Clinical Center (CC) | ||
| Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer | NCT02410603 | Lung Cancer Lung Neoplasms Cancer of Lung Cancer of the L... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Adenocarcinoma Squamous Cell C... | 18 Years - | Mayo Clinic | ||
| Application of Three-Dimensionally Printed Navigational Template in Lung Biopsy | NCT04775901 | Lung Neoplasms | CT-guided lung ... Template-guided... | 18 Years - 80 Years | Shanghai Pulmonary Hospital, Shanghai, China | |
| Deep Inspiration Breath Hold as Primary Strategy for Locally Advanced Lung Cancer Radiotherapy | NCT02540499 | Lung Neoplasms | DIBH VMAT | 18 Years - | Rigshospitalet, Denmark | |
| A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer | NCT01039948 | Carcinoma, Non-... Lung Neoplasms Lung Cancer Respiratory Tra... | AV-299 + gefiti... Gefitinib | 18 Years - | AVEO Pharmaceuticals, Inc. | |
| The DANTE Trial. A Randomized Study on Lung Cancer Screening With Low-Dose Spiral Computed Tomography | NCT00420862 | Lung Cancer | Spiral Computed... | 60 Years - 74 Years | Istituto Clinico Humanitas | |
| A Prospective Cohort of Pulmonary Ground Glass Nodules Patients With Family History. | NCT04220268 | Lung Neoplasms Family Research | - | Guangdong Provincial People's Hospital | ||
| Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC) | NCT00174772 | Lung Neoplasms | docetaxel and c... docetaxel and c... | 18 Years - 75 Years | Sanofi | |
| Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer | NCT00040560 | Lung Neoplasms Carcinoma, Non-... Brain Neoplasms Metastases, Neo... | 111In-DAC Diagnostic | 18 Years - | Copharos | |
| A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer | NCT02826161 | Carcinoma, Non-... | Napabucasin Paclitaxel | 18 Years - | Sumitomo Pharma America, Inc. | |
| Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma | NCT01950572 | Mesothelioma Thymoma Pancreatic Neop... Biliary Tract N... Stomach Neoplas... | 2 Years - | National Institutes of Health Clinical Center (CC) | ||
| A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLC | NCT04959981 | Advanced Non-sq... | ERAS-007 ERAS-601 Osimertinib Sotorasib | 18 Years - 99 Years | Erasca, Inc. | |
| Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | NCT00413322 | Tumor | belinostat 5-Fluorouracil ... | 18 Years - | Valerio Therapeutics | |
| A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) | NCT03157128 | Non-Small Cell ... Medullary Thyro... Colon Cancer Any Solid Tumor | LOXO-292 | 12 Years - | Eli Lilly and Company | |
| Lung Nodule Prospective Database | NCT03922828 | Lung Neoplasms Lung Cancer Lung Adenocarci... | CT scans | 21 Years - 120 Years | Singapore General Hospital | |
| Tax First-line Chemotherapy With Different Doses and Then Maintenance Therapy | NCT01038661 | Lung Neoplasms | Docetaxel Cisplatin Best supportive... | 18 Years - 75 Years | Sanofi | |
| DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer | NCT00339859 | Lung Neoplasms | 18 Years - 90 Years | National Institutes of Health Clinical Center (CC) | ||
| Lung Cancer Rehabilitation After Medical Treatment | NCT04185467 | Lung Neoplasms | Intervention (r... | 18 Years - 75 Years | Nantong University | |
| Treatment of Multifocal Lung Adenocarcinoma | NCT01946100 | Lung Neoplasms Carcinoma Non-s... Adenocarcinoma | Multifocal Lung... | 18 Years - | Mayo Clinic | |
| Specimen Banking From Patients With Lung Cancer | NCT01585675 | Lung Neoplasms | 18 Years - 85 Years | University of Colorado, Denver | ||
| Perioperative Specimen Imaging Using High-resolution 18F-FDG-PET-CT During Thoracic Surgery: a Pilot Study | NCT05693363 | Lung Neoplasms PET-CT Specimen... | AURA10 Specimen... | 18 Years - | University Hospital, Ghent |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
